Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Heilig

Showing results (1-10 of 313) with videos related to

Pageof 32
Sort By:
Addiction (Abingdon, England)|October 16, 2007
Imagen: implications for addiction science and science policyMarkus Heilig
The American Journal of Psychiatry|February 1, 2025
A Fresh Look at the Allostasis Theory of AddictionMarkus Heilig
Lakartidningen|December 18, 2013
[Opioid dependence: New national guidelines must allow maintenance treatment]Markus Heilig
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 13, 2014
Acamprosate: an alcoholism treatment that may not be what we thoughtMarkus Heilig
Addiction (Abingdon, England)|April 12, 2011
A welcome change that stops short of being fully satisfyingMarkus Heilig
Lakartidningen|February 13, 2002
[Surprising conclusion by the SBU concerning the benefits of naltrexone in the treatment of heroin dependence]Markus Heilig
Lakartidningen|March 8, 2002
[Documented effect of methadone, but not naltrexone]Markus Heilig
Neuropeptides|September 1, 2004
The NPY system in stress, anxiety and depressionMarkus Heilig
Lakartidningen|April 5, 2003
[Ecstasy is a dangerous drug the society chooses to ignore]Markus Heilig
Journal of Internal Medicine|April 13, 2023
Stress-related neuropeptide systems as targets for treatment of alcohol addiction: A clinical perspectiveMarkus Heilig
Pageof 32

Showing results (1-10 of 313) with videos related to

Sort By:
Pageof 32
Addiction (Abingdon, England)|October 16, 2007
Imagen: implications for addiction science and science policyMarkus Heilig
The American Journal of Psychiatry|February 1, 2025
A Fresh Look at the Allostasis Theory of AddictionMarkus Heilig
Lakartidningen|December 18, 2013
[Opioid dependence: New national guidelines must allow maintenance treatment]Markus Heilig
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 13, 2014
Acamprosate: an alcoholism treatment that may not be what we thoughtMarkus Heilig
Addiction (Abingdon, England)|April 12, 2011
A welcome change that stops short of being fully satisfyingMarkus Heilig
Lakartidningen|February 13, 2002
[Surprising conclusion by the SBU concerning the benefits of naltrexone in the treatment of heroin dependence]Markus Heilig
Lakartidningen|March 8, 2002
[Documented effect of methadone, but not naltrexone]Markus Heilig
Neuropeptides|September 1, 2004
The NPY system in stress, anxiety and depressionMarkus Heilig
Lakartidningen|April 5, 2003
[Ecstasy is a dangerous drug the society chooses to ignore]Markus Heilig
Journal of Internal Medicine|April 13, 2023
Stress-related neuropeptide systems as targets for treatment of alcohol addiction: A clinical perspectiveMarkus Heilig
Pageof 32